Brittney H. Cotta, MD
Department of Urology, Division of Surgery
About Dr. Brittney H Cotta
Dr. Cotta is a urologic oncologist specializing in the surgical treatment of cancers of the genitourinary system with expertise in both open and minimally invasive robotic surgical techniques. She earned her medical degree from Southern Illinois University School of Medicine in Springfield, IL, followed by an internship in general surgery and residency and chief residency in Urology at University of California San Diego. She then completed a Society of Urologic Oncology accredited fellowship at Memorial Sloan Kettering Cancer Center in New York, New York, and a NIH T32 research fellowship at University of Michigan. Dr. Cotta has numerous publications in peer-reviewed journals and her research interests include molecular characterization and biomarker development in kidney cancer. She currently holds a faculty position as Assistant Professor in the Department of Urology at MD Anderson Cancer Center in Houston, TX.
Read More
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2015 | Southern Illinois University School of Medicine, Springfield, IL, US, Medicine, Doctor of Medicine (MD) |
| 2009 | Bradley University, Peoria, Illinois, US, Chemistry (major), Psychology (minor), Bachelor of Science (BS) |
Postgraduate Training
| 2021-2023 | Research Fellow, Translational Research, University of Michigan, Ann Arbor, MI |
| 2020-2021 | Clinical Fellow, Urologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY |
| 2019-2020 | Chief Resident, Urology, University of California San Diego, San Diego, CA |
| 2016-2019 | Resident, Urology, University of California San Diego, San Diego, CA |
| 2015-2016 | Intern, General Surgery, University of California San Diego, San Diego, California |
Licenses & Certifications
| 2025 | Diplomate of the American Board of Urology |
| 2023 | Texas Medical Board |
Experience & Service
Intramural Institutional Committee Activities
Alternate Delegate, Value Analysis Team, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, EHR Committee, MD Anderson Cancer Center, 2025 - Present
Member, Care Team Transformation Steering Committee, MD Anderson Cancer Center, 2025 - Present
Extramural Institutional Committee Activities
Member, Research Climate Council Advisory Committee, University of Michigan, 2022 - 2023
Member, Ethics Committee, University of California San Diego Medical Center, 2019 - 2020
Member, Resident Physician Council Advisory Committee, University of California San Diego Medical Center, 2016 - 2017
Member, Human Values and Ethics Committee, Memorial Medical Center, 2014 - 2015
Student Representative, Year One Curriculum Committee, Southern Illinois University School of Medicine, 2011 - 2012
Editorial Activities
Guest Editor, Current Oncology, 2025 - Present
Honors & Awards
| 2025 | Urologic Oncology Fellowship Teaching Award, MD Anderson Cancer Center |
| 2024 | Top 1% of Providers for Patient Experience Nationally, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2023 | Best Reviewer, JU Open Plus |
| 2022 | Best Abstract Award, European Association of Urology Annual Meeting |
| 2022 | Best Poster Award, American Urological Association Annual Meeting |
| 2019 | George W. Kaplan Research Award, UCSD Department of Urology |
| 2018 | First Place Resident Essay Contest, San Diego Urologic Society |
| 2018 | Residents Bowl Champion, American Urological Association |
| 2018 | Earl F. Nation Resident Scholarship, Western Section of the American Urological Association |
| 2017 | Residents Bowl Champion, Western Section of the American Urological Association |
| 2017 | First Place Resident Research Presentation, San Diego Urologic Society |
| 2014 | Best Case Report: Male Sexual Health, Sexual Medicine Society of North America Annual Meeting |
| 2014 | Best Essay: Male Sexual Health, Sexual Medicine Society of North America Annual Meeting |
| 2014 | Peoria Medical Society Scholarship, Peoria Medical Society |
| 2012 | SIU Mentored Professional Enrichment Experience Scholarship, Société Internationale d'Urologie |
| 2009 | Cum Laude, Bradley University |
| 2005 | Honors Program, Bradley University |
| 2005 | Legacy Scholarship, Bradley University |
| 2005 | Presidential Scholarship, Bradley University |
| 2005 | Valedictorian, Pekin Community High School |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Genomic Biomarkers in Kidney Cancer: Challenges and Future Directions. Invited. University of Michigan Department of Urology Grand Rounds. Ann Arbor, Michigan, US.
Regional Presentations
- 2025. Kidney Cancer Session. Panelist. Annual Meeting of the South Central Section of the AUA, US.
- 2025. Challenges Cases in Kidney Cancer. Panelist. University of Texas 3rd Annual Christopher G. Wood Advances in Urologic Oncology Symposium, US.
- 2024. AUA 2024: Kidney Cancer Highlights. Invited. Texas Urological Society. Houston, TX, US.
- 2024. Radiogenomics in Kidney Cancer: What is the State of the Science?. Invited. University of Texas 2nd Annual Christopher G. Wood Advances in Urologic Oncology Symposium, US.
- 2023. Small renal mass management. Invited. UT Dr. Christopher G. Wood Advances in Urologic Oncology Symposium. Austin, Texas, US.
National Presentations
- 2025. Localized Kidney Cancer: How do I Select Patients for Surgery. Panelist. Society of Urologic Oncology Annual Meeting, US.
International Presentations
- 2025. Neoadjuvant Strategies in Locally Advanced Renal Cell Carcinoma. Invited. MD Anderson Cancer Center International GU Cancer Summit and Urologic Endoscopic Surgery Advancement Conference. Kaohsiung, TW.
- 2025. Complex Partial Nephrectomy:Surgical Techniques, Outcomes,and Case-Based Discussion. Invited. MD Anderson Cancer Center International GU Cancer Summit and Urologic Endoscopic Surgery Advancement Conference. Kaohsiung, TW.
Grant & Contract Support
| Date: | 2021 - 2023 |
| Title: | Ruth L. Kirschstein NRSA Institutional Research Training Grant |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | 5T32CA180984-06 |
Selected Publications
Peer-Reviewed Articles
- Ghasemzadeh A, Abel EJ, Karam JA, Spiess PE, Peyton CC, Manley BJ, Sirard RB, Robertson N, Ellis EE, Cotta BH, Patel KR, Nicaise E, Jani A, Sexton WJ, Patil D, Allen GO, Matin SF, Master VA, Shapiro DD. Risk Factors for First-Year Recurrence in Patients with Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy. J Urol:101097JU0000000000004705, 2025. e-Pub 2025. PMID: 40763351.
- Cotta, BH, Msaouel, P, Karam, JA. Surgical approaches following durable responses to immunotherapy. Kidney Cancer 9, 2025. e-Pub 2025.
- Patel P, Nallandhighal S, Scoville D, Cotta B, Knuth Z, Triner D, Tran L, Udager AM, Rao A, Morgan TM, Palapattu GS, Dadhania V, Pitchiaya S, Salami SS. Spatial Transcriptomic Profiling to Characterize the Nature of Peripheral- Versus Transition-zone Prostate Cancer. Eur Urol Focus 11(2):226-234, 2024. e-Pub 2024. PMID: 39613543.
- Mehra R, Nallandhighal S, Cotta B, Knuth Z, Su F, Kasputis A, Zhang Y, Wang R, Cao X, Udager AM, Dhanasekaran SM, Cieslik MP, Morgan TM, Salami SS. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma. JCO Precis Oncol 8:e2300565, 2024. e-Pub 2024. PMID: 38810179.
- Farha, M, Nallandhighal, S, Vince, R, Cotta, BH, Stangl-Kremser, J, Triner, D, Morgan, TM, Palapattu, GS, Cieślik, M, Vaishampayan, U, Udager, AM, Salami, SS. Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype. Cancers 15(23), 2023. e-Pub 2023. PMID: 38067234.
- Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel S, Master VA, Derweesh IH, Fujii Y. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma. Clin Genitourin Cancer 20(4):e276-e282, 2022. e-Pub 2022. PMID: 35410826.
- Meagher M, Patil D, Saito K, Javier-Desloges JF, Bradshaw AW, Patel S, Cotta BH, Yasuda Y, Eldefrawy A, Ghali F, Nasseri R, Wan F, Fujii Y, Master VA, Derweesh IH. Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma. Urology 163:164-176, 2022. e-Pub 2022. PMID: 34995562.
- Bell H, Cotta BH, Salami SS, Kim H, Vaishampayan U. "PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer. Kidney Cancer J 6(1):3-9, 2022. e-Pub 2022. PMID: 35310961.
- Cotta BH, Nguyen V, Sur RL, Bechis SK. Opiates prescribed for acute renal colic are associated with prolonged use. World J Urol 39(6):2183-2189, 2021. e-Pub 2021. PMID: 32740804.
- Ryan ST, Patel DN, Ghali F, Patel S, Sarkar R, Yim K, Eldefrawy A, Cotta BH, Bradshaw AW, Meagher M, Hamilton ZA, Murphy JD, Derweesh IH. Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer. Minerva Urol Nephrol 73(2):233-244, 2021. e-Pub 2021. PMID: 32748614.
- Cotta BH, Meagher M, Patil D, Saito K, Patel S, Patel DN, Miller NS, Dutt R, Keiner C, Bradshaw AW, Wan F, Eldefrawy A, Yasuda Y, Fujii Y, Master VA, Derweesh IH. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma. BJU Int 127(3):311-317, 2021. e-Pub 2021. PMID: 32772468.
- Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel S, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery. Clin Genitourin Cancer 18(2):111-116.e1, 2020. e-Pub 2020. PMID: 32001181.
- Hamilton ZA, Capitanio U, Pruthi D, Ghali F, Larcher A, Patel DN, Eldefrawy A, Patel S, Cotta BH, Bradshaw AW, Meagher M, Miller NS, Carenzi C, Wan F, Liss MA, McGregor T, Montorsi F, Derweesh IH. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease. Urology 138:60-68, 2020. e-Pub 2020. PMID: 31836465.
- Hamilton ZA, Capitanio U, Lane BR, Larcher A, Yim K, Dey S, Cotta BH, Meagher M, Kirmiz S, Bezinque A, Eldefrawy A, Bradshaw AW, Ryan ST, Carenzi C, Wan F, Proudfoot J, Montorsi F, Derweesh IH. Should partial nephrectomy be considered “elective” in patients with stage 2 chronic kidney disease?. World J Urol 37(11):2429-2437, 2019. e-Pub 2019. PMID: 30710156.
- Cotta BH, McCammon K, Rourke KF, Rosenstein D, Buckley JC. Training Genitourinary Reconstructive Surgeons. Urology 131:36-39, 2019. e-Pub 2019. PMID: 31136768.
- Field CA, Cotta BH, Jimenez J, Lane BR, Yim K, Lee HJ, Ryan ST, Hamilton ZA, Patel S, Wang S, Kane CJ, Dey S, McKay R, Noyes SL, Millard F, Rini BI, Campbell S, Derweesh IH. Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes. Clin Genitourin Cancer 17(3):e505-e512, 2019. e-Pub 2019. PMID: 30808547.
- Cotta BH, Welliver Jr RC, Brahmamdam A, Bednarchik CL, Dynda D, Köhler TS. Long-acting liposomal bupivacaine decreases inpatient narcotic requirements in men undergoing penile prosthesis implantation. Turk J Urol 42(4):230-234, 2016. e-Pub 2016. PMID: 27909614.
- Cotta BH, Butcher M, Welliver C, McVary KT, Köhler TS. Two Fungal Infections of Inflatable Penile Prostheses in Diabetics. Sex Med 3(4):339-342, 2015. e-Pub 2015. PMID: 26797070.
- Hanerhoff BL, Welliver C. Does Early Orchidopexy Improve Fertility?. Transl Androl Urol 3(4):370-376, 2014. e-Pub 2014. PMID: 26816793.
- Welliver Jr RC, Hanerhoff B, Henry GD, Köhler TS. Significance of Biofilm for the Prosthetic Surgeon. Current Urology Reports 15(6):411, 2014. e-Pub 2014. PMID: 24740272.
Review Articles
- Cotta BH, Choueiri TK, Cieślik M, Ghatalia P, Mehra R, Morgan TM, Palapattu GS, Shuch B, Vaishampayan U, Van Allen EM, Ari Hakimi A, Salami SS. Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. Eur Urol 84(2):166-175, 2023. e-Pub 2023. PMID: 37085424.
- Bell H, Cotta BH, Salami SS, Kim HL, Vaishampayan U. 'PROBE'ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer. Kidney Cancer J 6(1):3-9, 2022. e-Pub 2022.
- Berquist SW, Yim K, Ryan ST, Patel S, Eldefrawy A, Cotta BH, Bradshaw AW, Meagher M, Bindayi A, McKay R, Autorino R, Staehler M, Derweesh IH. Systemic therapy in the management of localized and locally advanced renal cell carcinoma. Int J Urol 26(5):532-542, 2019. e-Pub 2019. PMID: 30943578.
- Cotta BH, Meagher M, Bradshaw AW, Ryan ST, Rivera-Sanfeliz G, Derweesh IH. Percutaneous renal mass biopsy. Expert Rev Anticancer Ther 19(4):301-308, 2019. e-Pub 2019. PMID: 30656989.
- Cotta BH, Buckley JC. Endoscopic Treatment of Urethral Stenosis. Urol Clin North Am 44(1):19-25, 2017. e-Pub 2017. PMID: 27908368.
Professional Educational Materials
- Ryan ST, Cotta BH, Parsons JK. Approaching the Patient with Recurrence after Primary Radiation Therapy for Prostate Cancer. American Urological Association, 2019.
- Cotta BH, Parsons JK. The Metabolic Syndrome and Benign Urologic Diseases. American Urological Association, 2017.
Other Articles
- Cotta BH Editorial Comment. Journal of Urology 210(6):854, 2023. PMID: 37795824.
Editorials
- Cotta BH, Salami SS. Validation of a 22-Gene Epithelial Mesenchymal Transition Prognostic Signature in Renal Cell Carcinoma. AUA News, 2022.
Abstracts
- Cotta BH, Nallandhighal S, Triner D, Graham N, Mehra R, Cieslik M, Kasputis A, Morgan T, Salami S. Molecular Profiling Reveals Immunosuppressive Tumor Immune Microenvironment in Primary versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma. Annual Meeting of the American Urological Association 209(4S):e500, 2023. e-Pub 2023.
- Mehra R, Cieslik M, Kasputis A, Cotta B, Morgan T, Salami S. Whole Transcriptome Sequencing of Clear Cell Renal Cell Carcinoma Reveals a Multigene Expression Prognostic Signature. American Urological Association Annual Meeting 207(5S):e33, 2022. e-Pub 2022.
- Cotta B, Nallandhighal S, Hu K, Goldenthal S, Udager A, Salami S. Pan-Cancer Characterization of the Tumor Microenvironment Reveals Stroma and Immune Enriched Subtype with Distinct Molecular, Clinical, and Prognostic Features in Different Genitourinary Cancers. American Urological Association Annual Meeting 207(5S):e34, 2022. e-Pub 2022.
- Cotta BH, Nallandhighal S, Stangl-Kremser J, Pham T, Tosoian JJ, Marchetti K, Berends J, Maruf M, Tomlins SA, Morgan TM, Palapattu GS, Adbulfatah E, Udager AM, Salami S. Validation of a 22-Gene Epithelial-Mesenchymal Transition (EMT) Prognostic Signature in Clear Cell Renal Cell Carcinoma. American Urological Association Annual Meeting 207(5S):e810, 2022. e-Pub 2022.
- Nallandhighal S, Scoville D, Tran L, Cotta B, Udager A, Rao A, Palapattu G, Dadhania V, Pitchiaya S, Salami S. Spatial Transcriptomic Profiling of Prostate Cancer Reveals Zone Specific Androgen Receptor Signaling and Immune Infiltration. American Urological Association Annual Meeting 207(5S):e100, 2022. e-Pub 2022.
- Cotta BH, Nallandhighal S, Stangl-Kremser J, Pham T, Tosoian JJ, Marchetti K, Berends J, Maruf M, Tomlins SA, Morgan TM, Palapattu GS, Adbulfatah E, Udager AM, Salami S. Validation of a 22-Gene Epithelial-Mesenchymal Transition (EMT) Prognostic Signature in Clear Cell Renal Cell Carcinoma. American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium 40(6S):377, 2022. e-Pub 2022.
- Hamilton Z, Patil D, Saiko K, Bradshaw A, Patel S, Cotta B, Davaro-Comas F, Yasuda Y, Eldefrawy A, Ghali F, Nasseri R, Wan F, Fujii Y, Master V, Derweesh I. Elevated C-Reactive Protein is Associated with Postoperative Development of Proteinuria and Subsequent Renal Functional Decline and Mortality. American Urological Association Annual Meeting (cancelled) 203(4S):e257, 2020. e-Pub 2020.
- Hamilton Z, Patil D, Saiko K, Bradshaw A, Patel S, Cotta B, Davaro-Comas F, Yasuda Y, Eldefrawy A, Ghali F, Nasseri R, Wan F, Fujii Y, Master V, Derweesh I. Disparities in Survival Outcomes in African Americans in Renal Cell Carcinoma. American Urological Association Annual Meeting (cancelled) 203(4S):e1037-e1038, 2020. e-Pub 2020.
- Cotta BH, Saito K, Meagher M, Patil D, Eldefrawy A, Yosuda Y, Bradshaw A, Ryan S, Wan F, Master V, Fujii Y, Derweesh I. Elevated Pre-Operative C-Reactive Protein is Associated with Renal Functional Decline and Non-Cancer Mortality in Surgically Treated Renal Cell Carcinoma. American Urological Association Annual Meeting (cancelled) 203(4S):e758, 2020. e-Pub 2020.
- Cotta B, Rose B, Murphy JD, Ryan ST. Association of Salvage Cryoablation with Decreased Utilization of Androgen Deprivation Therapy for Recurrent Prostate Cancer after Radiotherapy. American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium 38(6S):358, 2020. e-Pub 2020.
- Cotta BH, McCammon KA, Rourke K, Rosenstein D, Buckley JC. Training Genitourinary Reconstructive Surgeons. American Urological Association Annual Meeting 131:36-39, 2019. e-Pub 2019.
- Cotta BH, Saito K, Meagher M, Patil D, Eldefrawy A, Yosuda Y, Bradshaw A, Ryan S, Anyakora D, Yee A, Alksne J, Wan F, Master V, Fujii Y, Derweesh I. Elevated C-Reactive Protein is Independently Associated with Progressive Renal Functional Decline after Surgery for Renal Cell Carcinoma. American Urological Association Annual Meeting 201(4S):e438-e439, 2019. e-Pub 2019.
- Bradshaw A, Capitanio U, Uzzo R, Patil D, Eldefrawy A, Larcher A, Joshi S, Ryan S, Meagher M, Cotta BH, Yee A, Wan F, Montorsi F, Master V, Derweesh I. Proposal for Tripartite Reclassification of cT1 Renal Cell Carcinoma into cT1a (Very Low Risk), cT1b (Low Risk), and cT1c (Intermediate Risk) Substages. American Urological Association Annual Meeting 201(4S):e143, 2019. e-Pub 2019.
- Fukushima H, Saito K, Yasuda Y, Tanabe K, Toide M, Fukuda S, Yokoyama M, Ishioka J, Matsuoka Y, Patil D, Cotta B, Patel S, Master V, Derweesh I, Fujii Y. Prognostic Impact of Sex in Non-Metastatic Clear Cell Renal Cell Carcinoma Patients Undergoing Curative Surgery. American Urological Association Annual Meeting 201(4S):e530, 2019. e-Pub 2019.
- Lane B, Larcher A, Patil D, Meagher M, Capitanio U, Noyes S, Eldefrawy A, Cotta BH, Bruinius J, Ryan S, Wan F, Montorsi F, Master V, Derweesh I. Comparison of Renal Functional Outcomes of Partial Nephrectomy vs. Angioembolization in the Treatment of Angiomyolipoma. American Urological Association Annual Meeting 201(4S):e290-e291, 2019. e-Pub 2019.
- Meagher M, Saito K, Patil D, Bindayi A, Eldefrawy A, Ryan S, Cotta B, Yim K, Nasseri R, Hamilton Z, Yasuda Y, Fujii Y, Master V, Derweesh I. Association of Elevated C-Reactive Protein with Oncologic Outcomes in Renal Cell Carcinoma. American Urological Association Annual Meeting 201(4S):e749, 2019. e-Pub 2019.
- Lane B, Bradshaw A, Noyes S, Eldefrawy A, Cotta B, Patel S, Bruinius J, Ryan S, Wan F, Derweesh I. Comparison of Renal Functional Outcomes of Active Surveillance and Partial Nephrectomy in the Management of Oncocytoma. American Urological Association Annual Meeting 201(4S):e615, 2019. e-Pub 2019.
- Bradshaw A, Uzzo R, Capitanio U, Patil D, Joshi S, Larcher A, Ryan S, Meagher M, Cotta B, Yee A, Wan F, Montorsi F, Master V, Derweesh I. Negative Impact of Positive Margins in Partial Nephrectomy in Stage I Renal Cell Carcinoma. American Urological Association Annual Meeting 201(4S):e832-e833, 2019. e-Pub 2019.
- Capitanio U, Pruthi D, Larcher A, Bindayi A, Ryan S, Eldefrawy A, Meagher M, Yim K, Patel S, Cotta B, Bradshaw A, Wan F, McGregor T, Montorsi F, Derweesh I. Dividing Pathologically Upstaged T3a Renal Cell Carcinoma based on Clinical T stage at Presentation is Associated with Improved Alignment of Outcomes. American Urological Association Annual Meeting 201(4S):e142-e143, 2019. e-Pub 2019.
- Saito K, Yasuda Y, Tanabe K, Fukuda S, Fukushima H, Yokoyama M, Ishioka J, Matsuoka Y, Patil D, Cotta B, Patel S, Master V, Derweesh I, Fujii Y. Prognostic Significance of C-reactive Protein on Survival in Patients with Non-Metastatic Papillary Renal Cell Carcinoma. American Urological Association Annual Meeting 201(4S):e277, 2019. e-Pub 2019.
- Cotta BH, Bechis S. Risk Factors for Prolonged Opiate Use in Patients with Acute Nephrolithiasis. American Urological Association Annual Meeting 201(4S):e843-e844, 2019. e-Pub 2019.
- Ryan S, Cotta B, Sarkar R, Bradshaw A, Meagher M, Hamilton Z, Murphy J, Derweesh I. Pattern of treatment approaches and outcome of Adrenocortical Carcinoma. American Urological Association Annual Meeting 201(4S):e989, 2019. e-Pub 2019.
- Cotta BH, Ryan S, Eldefrawy A, Sarkar R, Bradshaw A, Meagher MF, Hamilton Z, Murphy JD, Derweesh I. Does Increasing Time to Surgery Affect Survival in Stage 1 Renal Cell Carcinoma?. American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium 37(7S), 2019. e-Pub 2019.
- Meagher MF, Patil DH, Saito K, Cotta BH, Yasuda Y, Bradshaw A, Eldefrawy A, Ryan S, Nasseri R, Anyakora D, Alksne J, Wan F, Fujii Y, Master V, Derweesh I. Development and Validation of a Novel Scoring Index CART (C-reactive protein, age, race, and tumor size) to Predict Renal Functional Decline Post Partial Nephrectomy. Annual Meeting of the Society of Urologic Oncology 37(7S), 2019. e-Pub 2019.
- Hamilton Z, Nseyo U, Cotta BH, Schenker-Ahmed N, Karow D, Kader AK, Kane CJ, Parsons JK. Clinical Utility of MRI/Fusion Biopsy in Prostate Cancer Patients on Active Surveillance. American Urological Association Annual Meeting 197(4):e556, 2017. e-Pub 2017.
- Parsons JK, Ross A, Shafei AE, Hatem A, Cotta BH, Tay KJ, Polascik T, Given R, Mouraviev V, Jones JS. Salvage Prostate Cryoablation in Older Men. American Urological Association Annual Meeting 197(4S):e1116-e1117, 2017. e-Pub 2017.
- Triner D, Pham T, Nallandhighal S, Cotta BH, Knuth Z, Sun F, Udager A, Dhanasekaran S, Merrill N, Salami SS. Integrative Molecular Profiling of Renal Cell Carcinoma Native Tissue and Patient Derived Organoids Identifies Predictive Markers of Drug Resistance. American Urological Association Annual Meeting.
- Cotta BH, Nallandhighal S, Mehra R, Cieslik M, Farha M, Kasputis A, Morgan TM, Salami SS. Characterization of the Tumor Immune Microenvironment between Primary and Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma. European Association of Urology Annual Meeting.
- Cotta BH, Nallandhighal S, Stangl-Kremser J, Pham T, Tosoian JJ, Marchetti K, Berends J, Maruf M, Tomlins SA, Morgan TM, Palapattu GS, Adbulfatah E, Udager AM, Salami S. Validation of a 22-Gene Epithelial-Mesenchymal Transition (EMT) Prognostic Signature in Clear Cell Renal Cell Carcinoma. European Association of Urology Annual Meeting.
- King SA, McDonald ML, Fero KE, Cotta BH, Sakamoto K, Goldstein I. A Retrospective Review of Protocol-Based Intralesional Injection Therapy Management of Peyronie's Disease at the La Jolla Veteran's Administration Medical Center (VAMC). 17th Annual Fall Scientific Meeting of SMSNA.
- Hamilton Z, Nseyo U, Cotta BH, Schenker-Ahmed N, Karow D, Kader AK, Kane CJ, Parsons JK. Confirmatory MRI-guided Prostate Biopsy Informs Clinical Care in an Active Surveillance Protocol. Annual Meeting of the Society of Urologic Oncology.
- Parsons JK, Ross A, El Shafei A, Hatem A, Cotta BH, Tay KJ, Polascik T, Given R, Mouraviev V, Jones JS. Salvage Prostate Cryoablation in Older Men. European Association of Urology Annual Congress 16(3):e1328-e1329.
- Cotta BH, Millard F, Derweesh I, Kader AK, Kane CJ. Histologic Outcomes of Post-Chemotherapy Retroperitoneal Lymph Node Dissection. Western Section of the American Urological Association 93rd Annual Meeting.
- Hamilton Z, Nseyo U, Cotta BH, Schenker-Ahmed N, Karow D, Kader AK, Kane CJ, Parsons JK. MPMRI/Fusion-Guided Prostate Biopsy of PIRADS 4 and 5 Lesions Improves the Detection of Clinically Significant Cancer in Patients on Active Surveillance. Western Section of the American Urological Association 93rd Annual Meeting.
- Hamilton Z, Haifler M, Krabbe LM, Ryan ST, Reddy M, Berquist S, Clinton TN, Bloch A, Field C, Patel S, Cotta BH, Margulis V, Uzzo R, Derweesh I. Size-focality-invasion in Upper Tract Urothelial Carcinoma. American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) Symposium.
- Cotta BH, Patil D, Derweesh I, Nasseri R, Elbakry A, Melnick K, Pearl J, Bindayi A, Bilen MA, Ogan K, Master VA. External Validation of RISK Preoperative Inflammatory Score in Localized Renal Cell Carcinoma. Western Section of the American Urological Association 94th Annual Meeting.
- Cotta BH, Field CA, Jimenez J, Lane B, Lee H, Ryan ST, Hamilton Z, Wang S, Kane CJ, Dey S, McKay R, Noyes S, Millard F, Rini B, Campbell SC, Derweesh ID. Neoadjuvant Sunitinib is associated with Improved Oncologic Outcomes for Patients with Tumor Thrombus in Renal Cell Carcinoma. Western Section of the American Urological Association 94th Annual Meeting.
- Cotta BH, Bechis SK. Opiate Prescribing Patterns and Risk Factors for Prolonged Opiate Use in Patients with Acute Nephrolithiasis. Western Section of the American Urological Association 94th Annual Meeting.
- Cotta BH, Saito K, Meagher MF, Patil D, Eldefrawy A, Yosuda Y, Bradshaw A, Ryan S, Anyakora D, Yee A, Alksne J, Wan F, Master V, Fujii Y, Derweesh I. Elevated C-Reactive Protein is Independently Associated with Progressive Renal Functional Decline after Surgery for Renal Cell Carcinoma. Annual Meeting of the Society of Urologic Oncology.
- Cotta BH, Ryan S, Eldefrawy A, Sarkar R, Bradshaw A, Meagher MF, Hamilton Z, Murphy JD, Derweesh I. Does Increasing Time to Surgery Affect Survival in Stage 1 Renal Cell Carcinoma?. Annual Meeting of the Society of Urologic Oncology.
- Cotta BH, Saito K, Meagher M, Patil D, Eldefrawy A, Yosuda Y, Bradshaw A, Ryan S, Anyakora D, Yee A, Alksne J, Wan F, Master V, Fujii Y, Derweesh I. Elevated C-Reactive Protein is Independently Associated with Progressive Renal Functional Decline after Surgery for Renal Cell Carcinoma. European Association of Urology Annual Meeting.
- Korte KE, Hanerhoff B, Campbell DJ. Effects of Threonine on the Morphology of Noble Metal Colloids. Illinois State Academy of Science 100th Annual Meeting.
- Hanerhoff B. Memantine and Riluzole Do Not Reverse the Neurotoxic Effects Resulting from Chronic Exposure to Depleted Uranium. Society of Toxicology 51st Annual Meeting.
- Hanerhoff B, Myckatyn T. Economic Impact of AlloDerm on Prosthetic Breast Reconstruction. Southern Illinois University School of Medicine MPEE Research Symposium.
- Han K, Barbour JR, Kadkhodayan TS, Iorio ML, Hanerhoff B, Myckatyn TM. Analysis of the Deep and Superficial Inferior Epigastric Arteries Using Computed Tomographic Angiography. American Society of Plastic Surgeons Annual Meeting.
- Hanerhoff B, Welliver Jr RC, Brahmamdam A, Bednarchik CL, Dynda D, Köhler TS. Long-Acting Liposomal Bupivacaine Decreases Inpatient Narcotic Requirements in Men Undergoing Penile Prosthesis Implantation. 15th Annual Fall Scientific Meeting of SMSNA.
- Sulaver R, Welliver C, Kottwitz M, Frederick L, Hanerhoff B, Dynda D, Koehler T. Scrotoplasty at Time of Penile Implant is at High Risk for Dehiscence in Diabetics. American Urological Association Annual Meeting.
Book Chapters
- Ellis EE, Cotta BH, Merrill MM, Karam JA. Postoperative Surveillance Protocols for Renal Cell Carcinoma. In: Renal Cancer: Contemporary Management. 3. Springer Nature, 2025.
- Cotta BH, Welliver C, Wynia B. Penile Rehabilitation after Prostate Cancer Treatments. In: Contemporary Treatment of Erectile Dysfunction: A Clinical Guide. 2. Humana Press, 277-288, 2016.
Web Publications
- Cotta BH, Salami SS. AUA 2022: BEST POSTERS Validation of a 22-Gene Epithelial Mesenchymal Transition Prognostic Signature in Renal Cell Carcinoma.
Patient Reviews
CV information above last modified January 07, 2026